Ultralife Corporation (ULBI)
Official siteINDUSTRIALS • ELECTRICAL EQUIPMENT & PARTS • NASDAQ
Market Cap: $261.30M
Last updated: Nov 17, 2026 at 4:10 PM ET
Ultralife Corporation (ULBI) Statistics
Ultralife (ULBI) has a market cap of $261.30M and an enterprise value of $303.19M. It earned -$3.02M on revenue of $192.14M over the last 12 months.
Total Valuation
Enterprise value is 16.03% above the market cap, as debt exceeds cash.
| Market Cap | $261.30M |
|---|---|
| Enterprise Value | $303.19M |
| Latest price (Nov 17, 2026) | $15.67 |
Key Dates
The next earnings report is expected on Mar 8, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.4x and 1.9x. Its year-end P/S ranged from 0.5x to 1.2x from 2016 to 2025.
| P/S Ratio | 1.4x |
|---|---|
| Forward P/S | 1.2x |
| P/B Ratio | 1.9x |
| P/TBV Ratio | 3.3x |
| P/OCF Ratio | 130.5x |
Enterprise Valuation
Counting debt and cash, the company is valued at 75.9x EBITDA.
| EV / Sales | 1.6x |
|---|---|
| EV / EBITDA | 75.9x |
Price Statistics
The stock is up 181.83% over 52 weeks and trades 75.28% above its 50-day average.
| Beta (1Y) | 1.04 |
|---|---|
| 52-Week Change | +181.83% |
| 1-Month Change | +158.58% |
| 3-Month Change | +123.86% |
| 6-Month Change | +161.17% |
| 5-Year Change | +149.52% |
| 10-Year Change | +280.98% |
| Total Return (1Y) | +181.83% |
| Total Return (3Y CAGR) | +28.52% |
| Total Return (5Y CAGR) | +21.72% |
| Return vs SPY (1Y) | +198.74% |
| Max Drawdown (1Y) | -35.09% |
| Max Drawdown (3Y) | -68.83% |
| Sharpe Ratio (1Y) | 1.10 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $8.94 |
| 200-Day Average | $7.02 |
| 52-Week Range | $4.90 to $15.83 |
| RSI (14 Days) | 90.6 |
| Average Volume (20 Days) | 315.86K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.97x current liabilities, and total debt is 0.38x shareholder equity.
| Current Ratio | 2.97x |
|---|---|
| Quick Ratio | 1.38x |
| Debt / Equity | 0.38x |
| Debt / EBITDA | 12.65x |
| Interest Coverage | 5.28x |
Returns and Efficiency
Return on invested capital is -0.55% over the last 12 months, against a 5-year average of 1.71%.
| Return on Equity (ROE) | -2.25% |
|---|---|
| Return on Assets (ROA) | -1.35% |
| Return on Invested Capital (ROIC) | -0.55% |
| Return on Capital Employed (ROCE) | -0.85% |
| ROE (5Y Average) | 1.12% |
| ROA (5Y Average) | 0.79% |
| ROIC (5Y Average) | 1.71% |
| Asset Turnover | 0.86x |
| Inventory Turnover | 2.36x |
| Receivables Turnover | 5.45x |
| Cash Conversion Cycle | 168 days |
Scores
ULBI has an Altman Z-Score of 2.77, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.77 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $192.14M over the last 12 months is up 3.01% from the 12 months before.
| Revenue | $192.14M |
|---|---|
| Revenue Growth (YoY) | +3.01% |
| Gross Profit | $49.33M |
| Operating Income | -$4.20M |
| Pretax Income | -$5.14M |
| Net Income | -$3.02M |
| EBITDA | $3.99M |
| EBIT | -$1.57M |
| Reported EPS (TTM) | -$0.15 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 59.95% of the $224.40M in total assets.
| Cash and Equivalents | $8.63M |
|---|---|
| Total Debt | $50.52M |
| Net Debt | $41.89M |
| Net Debt Per Share | $2.51 |
| Working Capital | $77.33M |
| Shareholder Equity | $134.53M |
| Book Value Per Share | $8.07 |
| Tangible Book Value | $79.00M |
| Tangible Book Per Share | $4.74 |
| Total Assets | $224.40M |
| Total Liabilities | $89.77M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $2.70M of capital spending, operating cash flow left -$694.00K of free cash flow.
| Operating Cash Flow | $2.00M |
|---|---|
| Capital Expenditures | $2.70M |
| Free Cash Flow | -$694.00K |
| FCF Per Share | -$0.04 |
| Depreciation and Amortization | $5.57M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -2.18%, against a 5-year average of 1.82%.
| Gross Margin | 25.67% |
|---|---|
| Operating Margin | -2.18% |
| Pretax Margin | -2.67% |
| Net Margin | -1.57% |
| EBITDA Margin | 2.08% |
| EBIT Margin | -0.82% |
| FCF Margin | -0.36% |
| Gross Margin (5Y Average) | 24.38% |
| Operating Margin (5Y Average) | 1.82% |
| Net Margin (5Y Average) | 1.00% |
Growth
Revenue grew 13.18% a year over 3 years.
| Revenue Growth (3Y CAGR) | +13.18% |
|---|---|
| Revenue Growth (5Y CAGR) | +12.16% |
| FCF Growth (5Y CAGR) | -17.49% |
| Book Value Per Share Growth (2Y CAGR) | +1.31% |
| Tangible Book Per Share Growth (2Y CAGR) | +0.18% |
Dividends and Yields
ULBI does not pay a dividend. Its free cash flow yield is -0.27%.
| FCF Yield | -0.27% |
|---|---|
| Shareholder Yield | 0.00% |
Peer Position
Against 11 similar companies, ULBI has the 7th highest P/S and the 5th highest ROIC.
P/S RatioPeer median 2.0x
ROICPeer median -11.89%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.04%
| P/S Ratio | 1.4x vs 2.0x median |
|---|---|
| ROIC | -0.55% vs -11.89% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +3.01% vs +13.04% median |
Analyst Forecast
Consensus estimates put revenue growth at 17.65% a year over the next fiscal year.
| Revenue Growth Forecast (1Y CAGR) | +17.65% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ULBI
What is ULBI's market cap?
Ultralife has a market cap of $261.30M. Its enterprise value, which adds debt and subtracts cash, is $303.19M.
How many shares of ULBI are outstanding?
Ultralife has 16.66M shares outstanding. The count is up 0.11% from a year earlier.
Does ULBI pay a dividend?
No. Ultralife does not pay a dividend.
How much debt does ULBI have?
Ultralife has $50.52M of total debt and $8.63M of cash and equivalents, a net debt position of $41.89M.
ULBI pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors, Government Contracts